StemRegenin-1

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameStemRegenin-1
Drug Alias NameStemRegenin-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAryl hydrocarbon receptor antagonists
TargetsAryl hydrocarbon receptor
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A